statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire...

TCBP Announces Launch of Compassionate Use Program for TCB008

TCBP Announces Launch of Compassionate Use Program for TCB008 TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire EDINBURGH, Scotland, May 15, 2024 The Company's lead...

TC BioPharm Announces Exercise of Warrants for 3.1 Million Gross Proceeds

TC BioPharm Announces Exercise of Warrants for 3.1 Million Gross Proceeds TC BioPharm Announces Exercise of Warrants for 3.1 Million Gross Proceeds PR Newswire EDINBURGH, Scotland, May 6, 2024...

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for...

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform...

TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics

TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics...

TC Biopharm announces plans to increase treatments capacity and reduce costs

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process TCBP Increasing Treatment Capacity with Expanded Manufacturing Process PR Newswire EDINBURGH, Scotland, April 2, 2024 Developing...

TCBP Adjourns General Meeting Until a Later Date

TCBP Adjourns General Meeting Until a Later Date TCBP Adjourns General Meeting Until a Later Date PR Newswire EDINBURGH, Scotland, March 19, 2024 EDINBURGH, Scotland, March 19, 2024 /PRNewswire...

TCBP Announces Exercise of Series D Warrants For Cash

TCBP Announces Exercise of Series D Warrants For Cash TCBP Announces Exercise of Series D Warrants For Cash PR Newswire EDINBURGH, Scotland, March 18, 2024 Company receives gross proceeds of $1.26 M...

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

Volume	41,882.00
52-Wk High	$19.60
52-Wk Low	$0.7212

TCBP TC BioPharm Holdings Ltd

About

Feed

News

Fundamentals